Skip to main content

Table 2 Haemodynamic and perfusion data at baseline and during hyperaemia in controls and diabetics.

From: Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats

Variable

Baseline

Hyperemia

Controls

Diabetics

p

Controls

Diabetics

p

Heart rate, min-1

318 ± 27

299 ± 33

NS

315 ± 29

316 ± 25

NS

SBP, mm Hg

131 ± 7

131 ± 13

NS

96 ± 3

100 ± 6

NS

RPP, min-1 mm Hg

41,342 ± 1,234

39,056 ± 1,324

NS

31,339 ± 1,567

31,561 ± 1,234

NS

MBF, ml·min -1·g -1

2.42 ± 0.823

3.75 ± 0.943

NS

5.81 ± 0.99

5.02 ± 0.76

NS

β, min-1

23.3 ± 8.2

27.6 ± 9.1

†

32.3 ± 7.7

37.4 ± 9.9

†

rBV, ml·min -1

0.112 ± 0.045

0.120 ± 0.05

NS

0.191 ± 0.046

0.141 ± 0.043

*

  1. Values are mean ± SD. *p = 0.0001; †p = 0.005.
  2. MBF = myocardial blood flow; rBV = relative blood volume;
  3. RPP = rate-pressure product; SBP = systolic blood pressure.